Dailies from reputable brands, like the Bausch + Lomb BioTrue Onedays, are an affordable, safe option for those on a budget. As Ferri says, steer clear of cheap off-brand lenses, which can present ...

The system aids in the orthokeratology lens design process by syncing directly with topographers to create precise lens ...

Bausch + Lomb announced today that it launched Arise, its intelligent, cloud-based lens-fitting system, in the U.S.

This is a developing news story. Please check back soon for updates. Arise, a lens fitting system that streamlines the ...

Bausch + Lomb reported solid Q4 and full-year 2024 earnings, with CEO Brent Saunders highlighting positives while avoiding the critical issue of Bausch Health's potential sale of its 88% stake.

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb (BLCO) chairman and CEO Brent Saunders won't be making in 2025. The one for his contact ...

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

Bausch & Lomb is one of the largest vision care companies ... We expect patents and product superiority of Biotrue eye drops, Lumify, and PreserVision to secure Bausch as a leader in the over ...

Eyecare company Bausch + Lomb (NYSE:BLCO) will be announcing earnings results tomorrow morning. Here’s what to expect. Bausch + Lomb beat analysts’ revenue expectations by 1.6% last quarter ...